NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDBerotralstat Orladeyo®
(150 mg hard capsules) 		Respiratory system, Angioedema, 03.04.03
REDC1 Esterase Inhibitor Berinert® Respiratory system, Angioedema, 03.04.03
REDFluocinolone 190microgram Iluvien®
(Intravitreal Implant ) 		Eye, Corticosteroids, 11.04.01
REDGaradacimab Andembry®
(200 mg Solution for injection in pre-filled pen) 		Respiratory system, Angioedema, 03.04.03
REDLanadelumab Takhzyro®
(300mg solution for injection) 		Respiratory system, Angioedema, 03.04.03
REDLiothyronine
(Injection) 		Endocrine system, Thyroid hormones, 06.02.01
REDRanibizumab 10mg/ml intravitreal injection
(Intravitreal Injection ) 		Eye, Subfoveal choroidal neovascularisation, 11.08.02
GREENSodium Chloride 5% eye products  Eye, Tear deficiency, ocular lubricants, and astringents, 11.08.01
Non Formulary items found
Status Description Section
 Lymphoedema garments  Miscellaneous, Medical Devices and other products, 16.01
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Aflibercept Aflibercept [Specialist Drug] Eye, Macular Oedema, Retinopathy Of Prematurity, Antineoplastic Drugs Antineoplastics, Other
Aflibercept Aflibercept [Specialist Drug] Eye, Macular Oedema, Retinopathy Of Prematurity, Antineovascularisation Drugs Vascular Endothelial Growth Factor Inhibitors
Amiloride  Amiloride Hydrochloride Cardiovascular System, Oedema, Diuretics Potassium-Sparing Diuretics
Amiloride  Amiloride With Bumetanide Cardiovascular System, Oedema, Diuretics Loop Diuretics
Amiloride  Amiloride With Bumetanide Cardiovascular System, Oedema, Diuretics Potassium-Sparing Diuretics
Berotralstat Berotralstat Respiratory System, Allergic Conditions, Angioedema, Drugs Used In Hereditary Angioedema Kallikrein Inhibitors
Brolucizumab Brolucizumab [Specialist Drug] Eye, Retinal Disorders, Macular Oedema, Antineovascularisation Drugs Vascular Endothelial Growth Factor Inhibitors
Bumetanide Bumetanide Cardiovascular System, Oedema, Diuretics Loop Diuretics
C1-Esterase C1-Esterase Inhibitor Respiratory System, Allergic Conditions, Angioedema, Drugs Used In Hereditary Angioedema Complement Regulatory Proteins
Chlortalidone  Chlortalidone Cardiovascular System, Oedema, Diuretics Thiazides And Related Diuretics
Chlortalidone  Chlortalidone Cardiovascular System, Oedema, Ascites, Diuretics Thiazides And Related Diuretics
Co-amilofruse Co-Amilofruse Cardiovascular System, Oedema, Diuretics Loop Diuretics
Co-amilofruse Co-Amilofruse Cardiovascular System, Oedema, Diuretics Potassium-Sparing Diuretics
Co-amilozide Co-Amilozide Cardiovascular System, Oedema, Ascites, Diuretics Potassium-Sparing Diuretics
Co-amilozide Co-Amilozide Cardiovascular System, Oedema, Ascites, Diuretics Thiazides And Related Diuretics
Conestat Conestat Alfa Respiratory System, Allergic Conditions, Angioedema, Drugs Used In Hereditary Angioedema Complement Regulatory Proteins
Dexamethasone Dexamethasone Eye, Retinal Disorders, Macular Oedema
Diamorphine  Diamorphine Hydrochloride Cardiovascular System, Oedema, Analgesics Opioids
Faricimab  Faricimab [Specialist Drug] Eye, Retinal Disorders, Macular Oedema, Antineovascularisation Drugs Vascular Endothelial Growth Factor Inhibitors
Fluocinolone  Fluocinolone Acetonide Eye, Retinal Disorders, Macular Oedema
Furosemide Furosemide Cardiovascular System, Oedema, Diuretics Loop Diuretics
Furosemide Furosemide With Triamterene Cardiovascular System, Oedema, Diuretics Loop Diuretics
Furosemide Furosemide With Triamterene Cardiovascular System, Oedema, Diuretics Potassium-Sparing Diuretics
Garadacimab Garadacimab Respiratory System, Allergic Conditions, Angioedema
IcatibantIcatibant Respiratory System, Allergic Conditions, Angioedema, Drugs Used In Hereditary Angioedema Selective Bradykinin B2 Antagonists
Lanadelumab  Lanadelumab Respiratory System, Allergic Conditions, Angioedema, Drugs Used In Hereditary Angioedema Kallikrein Inhibitors
Mannitol Mannitol Cardiovascular System, Oedema
Mannitol Mannitol Cardiovascular System, Oedema, Diuretics Osmotic Diuretics
Metolazone Metolazone Cardiovascular System, Oedema, Diuretics Thiazides And Related Diuretics
Ranibizumab  Ranibizumab [Specialist Drug] Eye, Retinal Disorders, Macular Oedema, Antineovascularisation Drugs Vascular Endothelial Growth Factor Inhibitors
Spironolactone  Spironolactone Cardiovascular System, Oedema, Ascites, Diuretics Potassium-Sparing Diuretics
Spironolactone  Spironolactone With Furosemide Cardiovascular System, Oedema, Diuretics Loop Diuretics
Spironolactone  Spironolactone With Furosemide Cardiovascular System, Oedema, Diuretics Potassium-Sparing Diuretics
Torasemide  Torasemide Cardiovascular System, Oedema, Diuretics Loop Diuretics
TriamtereneTriamterene Cardiovascular System, Oedema, Diuretics Potassium-Sparing Diuretics
Triamterene Triamterene With Chlortalidone Cardiovascular System, Oedema, Diuretics Potassium-Sparing Diuretics
Triamterene Triamterene With Chlortalidone Cardiovascular System, Oedema, Diuretics Thiazides And Related Diuretics
XipamideXipamide Cardiovascular System, Oedema, Diuretics Thiazides And Related Diuretics
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
NICE TA 606 Lanadelumab for preventing recurrent attacks of hereditary angioedema
NICE TA 738 Berotralstat for preventing recurrent attacks of hereditary angioedema
NICE TA1004: Faricimab for treating visual impairment caused by macular oedema after retinal vein occlusion
NICE TA1101: Garadacimab for preventing recurrent attacks of hereditary angioedema in people 12 years and over
NICE TA229: Dexamethasone intravitreal implant for the treatment of macular oedema
NICE TA274: Macular oedema (diabetic) - ranibizumab
NICE TA283: Macular oedema (retinal vein occlusion) - ranibizumab: guidance
NICE TA301: Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema after an inadequate response to prior therapy (replaced by NICE TA953)
NICE TA305: Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion
NICE TA346: Aflibercept for treating diabetic macular oedema
NICE TA349: Dexamethasone intravitreal implant for treating diabetic macular oedema
NICE TA613: Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema in phakic eyes after an inadequate response to previous therapy (replaced by NICE TA953)
NICE TA799 Faricimab for treating diabetic macular oedema
NICE TA820: Brolucizumab for treating diabetic macular oedema
NICE TA824: Dexamethasone intravitreal implant for treating diabetic macular oedema
NICE TA953: Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema